Diclofenac analgesia following cleft palate surgery

P Sylaidis1, T J O'Neill

  • 1Department of Plastic and Reconstructive Surgery, Norfolk and Norwich Hospital, United Kingdom.

Insights

Diclofenac rectal suppositories, combined with paracetamol, effectively manage pain after cleft palate repair. This approach avoids opiates, leading to better infant recovery and earlier discharge.

Area of Science:

  • Pediatric Surgery
  • Pharmacology
  • Anesthesiology

Background:

  • Postoperative pain management is crucial for pediatric surgical recovery.
  • Nonsteroidal anti-inflammatory drugs (NSAIDs) like diclofenac are widely used for analgesia.
  • Opioid use in infants can lead to respiratory depression and feeding difficulties.

Purpose of the Study:

  • To evaluate the postoperative hemorrhage risk of diclofenac in children undergoing cleft palate repair.
  • To assess the efficacy of diclofenac suppositories for analgesia in this patient group.

Main Methods:

  • A prospective study included twenty children aged 6 months to 9 years undergoing cleft palate repair.
  • Diclofenac was administered rectally at 1 mg/kg post-surgery, with doses every 12 hours.
  • Oral paracetamol was used as a supplemental analgesic.

Main Results:

  • Diclofenac suppositories provided effective analgesia following cleft palate repair.
  • The combination of diclofenac and paracetamol eliminated the need for opioid analgesics.
  • Infants were alert, fed well, and suitable for early discharge.

Conclusions:

  • Rectal diclofenac, supplemented with oral paracetamol, is a safe and effective analgesic regimen for post-cleft palate repair.
  • This opioid-sparing strategy enhances infant recovery and facilitates early hospital discharge.
  • Diclofenac demonstrates a favorable risk-benefit profile for pediatric postoperative pain management.
Abstract